Robert Lawrence Golden - 07 Dec 2023 Form 4 Insider Report for OneMedNet Corp (ONMD)

Reporting relationship: Chief Financial Officer, Director
Issuer ticker: ONMD
Reported as of: 07 Dec 2023
Net transaction value: +$513
SEC form: 4
Accepted by SEC: 26 Nov 2025, 21:54:55 UTC
Prior SEC filing: 26 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Robert Golden

Key filing fact

Robert Lawrence Golden filed Form 4 for OneMedNet Corp (ONMD) on 26 Nov 2025.

Key facts

This page summarizes Robert Lawrence Golden's Form 4 filing for OneMedNet Corp (ONMD).
7 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 26 Nov 2025, 21:54.

Change

Previous filing in this sequence was filed on 26 Nov 2025.
Current net transaction value: +$513.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001585507 Primary reporting owner

Golden Robert Lawrence

Relationship: Chief Financial Officer, Director
Address: 6385 OLD SHADY OAK ROAD, SUITE 250, EDEN PRAIRIE
Signature: /s/ Robert Golden
Signature date: 26 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONMD transaction

Common Stock

Purchase

Transaction value: $513
Shares: +300
Change %
Price: $1.71
Shares after: 300
Date: 07 Dec 2023
Ownership: Direct

ONMD transaction

Common Stock

Award

Transaction value: $0
Shares: +45,000
Change %: +15000%
Price: $0.000000
Shares after: 45,300
Date: 19 Jan 2024
Ownership: Direct
Footnotes: F1

ONMD transaction

Common Stock

Award

Transaction value: $0
Shares: +100,000
Change %: +221%
Price: $0.000000
Shares after: 145,300
Date: 30 Aug 2024
Ownership: Direct
Footnotes: F2

ONMD transaction

Common Stock

Award

Transaction value: $0
Shares: +24,272
Change %: +17%
Price: $0.000000
Shares after: 169,572
Date: 31 Jan 2025
Ownership: Direct
Footnotes: F3

ONMD transaction

Common Stock

Award

Transaction value: $0
Shares: +300,000
Change %: +177%
Price: $0.000000
Shares after: 469,572
Date: 24 Nov 2025
Ownership: Direct
Footnotes: F4

ONMD transaction

Common Stock

Award

Transaction value: $0
Shares: +33,333
Change %: +7.1%
Price: $0.000000
Shares after: 502,905
Date: 24 Nov 2025
Ownership: Direct
Footnotes: F5

ONMD transaction

Common Stock

Award

Transaction value: $0
Shares: +45,000
Change %: +8.9%
Price: $0.000000
Shares after: 547,905
Date: 26 Nov 2025
Ownership: Direct
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vested on December 31, 2024.

Footnote F2

Represents RSUs granted pursuant to a consulting agreement with the reporting person. The RSUs vested on August 30, 2025.

Footnote F3

Represents RSUs granted in lieu of a cash bonus pursuant to contractor arrangements with the reporting person in connection with his appointment as permanent Chief Financial Officer. The RSUs fully vested on the grant date.

Footnote F4

Represents RSUs granted pursuant to contractor arrangements with the reporting person. The RSUs vest with respect to 1/3 of the shares on the first anniversary of the vesting start date of January 1, 2025, with the remaining RSUs vesting in equal quarterly installments on the last day of each fiscal quarter over 24 months thereafter, subject to the reporting person's continued service with the issuer through each vesting date.

Footnote F5

Represents RSUs granted pursuant to contractor arrangements with the reporting person. The RSUs vest in full on December 31, 2025, subject to the terms of Section 7.2.2 of the Consulting Agreement, dated August 30, 2024, between the issuer and Mr. Golden.

Footnote F6

Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.